RU94042198A - Method of person selection suffering with obesity for treatment by relief-dietetic therapy - Google Patents

Method of person selection suffering with obesity for treatment by relief-dietetic therapy

Info

Publication number
RU94042198A
RU94042198A RU94042198/14A RU94042198A RU94042198A RU 94042198 A RU94042198 A RU 94042198A RU 94042198/14 A RU94042198/14 A RU 94042198/14A RU 94042198 A RU94042198 A RU 94042198A RU 94042198 A RU94042198 A RU 94042198A
Authority
RU
Russia
Prior art keywords
obesity
treatment
relief
suffering
dietetic therapy
Prior art date
Application number
RU94042198/14A
Other languages
Russian (ru)
Other versions
RU2083987C1 (en
Inventor
Т.П. Демичева
Original Assignee
Пермская государственная медицинская академия
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пермская государственная медицинская академия filed Critical Пермская государственная медицинская академия
Priority to RU94042198A priority Critical patent/RU2083987C1/en
Publication of RU94042198A publication Critical patent/RU94042198A/en
Application granted granted Critical
Publication of RU2083987C1 publication Critical patent/RU2083987C1/en

Links

Landscapes

  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Steroid Compounds (AREA)

Abstract

FIELD: medicine, endocrinology. SUBSTANCE: method involves determination of hormones: cortisol and T, in patient blood. Carrying out relief-dietetic therapy is considered to be not advisable at cortisol blood content above 560 nM and that of T- less 1.9 nM. EFFECT: enhanced effectiveness of therapy.

Claims (1)

Использование: медицина, эндокринология, для лечения больных ожирением Для повышения эффективности разгрузочно-диетической терапии при ожирении за счет отбора больных в крови пациента определяют содержание гормонов - кортизола и Тз и при содержании в крови кортизола более 560 нмоль/л и Тз менее 1,9 нмоль/л делают вывод о нецелесообразности проведения РДТ.Usage: medicine, endocrinology, for the treatment of patients with obesity To increase the effectiveness of unloading and dietary therapy for obesity by selecting patients in the patient’s blood, the hormones cortisol and Tz are determined and when the cortisol content in the blood is more than 560 nmol / l and Tz is less than 1.9 nmol / l conclude that it is inappropriate to conduct RTD.
RU94042198A 1994-11-24 1994-11-24 Method for selecting persons affected with obesity for fasting dietary treatment RU2083987C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94042198A RU2083987C1 (en) 1994-11-24 1994-11-24 Method for selecting persons affected with obesity for fasting dietary treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94042198A RU2083987C1 (en) 1994-11-24 1994-11-24 Method for selecting persons affected with obesity for fasting dietary treatment

Publications (2)

Publication Number Publication Date
RU94042198A true RU94042198A (en) 1996-09-27
RU2083987C1 RU2083987C1 (en) 1997-07-10

Family

ID=20162662

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94042198A RU2083987C1 (en) 1994-11-24 1994-11-24 Method for selecting persons affected with obesity for fasting dietary treatment

Country Status (1)

Country Link
RU (1) RU2083987C1 (en)

Also Published As

Publication number Publication date
RU2083987C1 (en) 1997-07-10

Similar Documents

Publication Publication Date Title
US4953565A (en) Endermic application kits for external medicines
BG60253B1 (en) HUMAN TISSUE PLASMINOGENIC ACTIVATOR
ATE287271T1 (en) USE OF VEGF FOR PRODUCING A MEDICATION FOR TREATING OR PREVENTING INTIMAL HYPERPLASIA AND ADMINISTRATION DEVICE
FI922325A0 (en) ORAL SAMMANSAETTNING FOER BOTNING AV INFLAMMATORISKA TARMKANALSJUKDOMAR.
GB8805792D0 (en) Medicaments
RU94042198A (en) Method of person selection suffering with obesity for treatment by relief-dietetic therapy
GEP20002257B (en) Method for Reducing Fibrin Accumulation Speed, Prophylactics of Thrombus Complications and Treatment of Blood Vessels Diseases, Medicinal Composition and Medicinal Species
US20030064123A1 (en) DHEA supplement for increasing women's libido
RU92005071A (en) Slimming Method
RU2269369C1 (en) Method for treating the cases of chronic prostatitis combined with benign prostate hyperplasia
KR890015746A (en) How to treat AIDS cachexia with megestrol acetate
RU2099061C1 (en) Method for treating the cases of neurodermite
Price Back pain
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
WO1997035884A8 (en) Improved production of antibodies through the use of combinations of antigen and antibody, test kits incorporating said antibodies, and medical uses of said antibodies
Ogihara et al. Effect of alacepril on quality of life in the treatment of hypertension.
RU2152744C2 (en) Syrup
RU2067007C1 (en) Method for treating burnt patients
RU94039630A (en) Device for treatment of biological object
王小马 ELECTROIMPULSE ACUPUNCTURE TREATMENT OF 110 CASES OF ABDOMINAL PAIN AS A SEOUELA OF ABDOMINAL SURGERY
FR2584928A1 (en) New therapeutic compound for the treatment, in particular, of migraine and head colds
Maciejewski et al. Radiobiological predictors of tumor and acute normal tissue response in radiotherapy for head and neck cancers
RU95107493A (en) Method to treat parenchymatous tumors
Yoichi et al. The Effects of Red Ginseng on Blood Pressure and the Quality of Life in Essential Hypertensives
RU94010421A (en) Method for treating moderately severe and severe degree facial nerve neuropathy